Giuseppe Ronzitti (G Ronzitti)

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 14

Top Venues

Nature communications

Expert opinion on biological therapy

Science advances

Journal of inherited metabolic disease

Istituto Italiano di Tecnologia

University of Bologna (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istituto Italiano di Tecnologia Aug 01 2008 - Jul 31 2013

Italy

Post doctoral fellowship :: Neuroscience and Brain Technologies

Education History

University of Bologna Nov 01 2004 - Jun 01 2008

Italy

PHD :: Biochemistry

University of Modena Sep 01 1998 - Jul 21 2003

Italy

BSC :: Industrial Biotechnology

Publications

Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti, Emanuela Zuccaro, Davide Dalfovo, Caterina Marchioretti, Debasmita Tripathy, Gianluca Petris, Eric N Anderson, Alice Migazzi, Laura Tosatto, Anna Cereseto, Elena Battaglioli, Gianni Sorarù, Wooi Fang Lim, Carlo Rinaldi, Fabio Sambataro, Naemeh Pourshafie, Christopher Grunseich, Alessandro Romanel, Udai Bhan Pandey, Andrea Contestabile, Giuseppe Ronzitti, Manuela Bassoi, Maria Pennuto
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice. Nature communications 14 (1) (2023)
Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti, Emanuela Zuccaro, Davide Dalfovo, Caterina Marchioretti, Debasmita Tripathy, Gianluca Petris, Eric N Anderson, Alice Migazzi, Laura Tosatto, Anna Cereseto, Elena Battaglioli, Gianni Sorarù, Wooi Fang Lim, Carlo Rinaldi, Fabio Sambataro, Naemeh Pourshafie, Christopher Grunseich, Alessandro Romanel, Udai Bhan Pandey, Andrea Contestabile, Giuseppe Ronzitti, Manuela Bassoi, Maria Pennuto
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice. Nature communications 14 (1) (2023)
P Sellier, P Vidal, B Bertin, E Gicquel, null Bertil-Froidevaux, C Georger, L van Wittenberghe, A Miranda, N Daniele, I Richard, D A Gross, F Mingozzi, F Collaud, Giuseppe Ronzitti
Muscle-specific, liver-detargeted AAV gene therapy rescues Pompe phenotype in adult and neonate Gaa -/- mice. Journal of inherited metabolic disease (2023)
Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti, Emanuela Zuccaro, Davide Dalfovo, Caterina Marchioretti, Debasmita Tripathy, Gianluca Petris, Eric N Anderson, Alice Migazzi, Laura Tosatto, Anna Cereseto, Elena Battaglioli, Gianni Sorarù, Wooi Fang Lim, Carlo Rinaldi, Fabio Sambataro, Naemeh Pourshafie, Christopher Grunseich, Alessandro Romanel, Udai Bhan Pandey, Andrea Contestabile, Giuseppe Ronzitti, Manuela Bassoi, Maria Pennuto
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice. Nature communications 14 (1) (2023)
Ramachandran Prakasam, Angela Bonadiman, Roberta Andreotti, Emanuela Zuccaro, Davide Dalfovo, Caterina Marchioretti, Debasmita Tripathy, Gianluca Petris, Eric N Anderson, Alice Migazzi, Laura Tosatto, Anna Cereseto, Elena Battaglioli, Gianni Sorarù, Wooi Fang Lim, Carlo Rinaldi, Fabio Sambataro, Naemeh Pourshafie, Christopher Grunseich, Alessandro Romanel, Udai Bhan Pandey, Andrea Contestabile, Giuseppe Ronzitti, Manuela Bassoi, Maria Pennuto
LSD1/PRMT6-targeting gene therapy to attenuate androgen receptor toxic gain-of-function ameliorates spinobulbar muscular atrophy phenotypes in flies and mice. Nature communications 14 (1) (2023)
Sem J Aronson, Giuseppe Ronzitti, Piter J Bosma
What's next in gene therapy for Crigler-Najjar syndrome? Expert opinion on biological therapy 23 (2) (2022)
Sem J Aronson, Giuseppe Ronzitti, Piter J Bosma
What's next in gene therapy for Crigler-Najjar syndrome? Expert opinion on biological therapy 23 (2) (2022)
Sem J Aronson, Giuseppe Ronzitti, Piter J Bosma
What's next in gene therapy for Crigler-Najjar syndrome? Expert opinion on biological therapy 23 (2) (2022)
Jihad El Andari, Edith Renaud-Gabardos, Warut Tulalamba, Jonas Weinmann, Louise Mangin, Quang Hong Pham, Susanne Hille, Antonette Bennett, Esther Attebi, Emanuele Bourges, Christian Leborgne, Nicolas Guerchet, Julia Fakhiri, Chiara Krämer, Ellen Wiedtke, Robert McKenna, Laurence Guianvarc'h, Magali Toueille, Giuseppe Ronzitti, Matthias Hebben, Federico Mingozzi, Thierry VandenDriessche, Mavis Agbandje-McKenna, Oliver J Müller, Marinee K Chuah, Ana Buj-Bello, Dirk Grimm
Semirational bioengineering of AAV vectors with increased potency and specificity for systemic gene therapy of muscle disorders. Science advances 8 (38) (2022)
Sem J Aronson, Giuseppe Ronzitti, Piter J Bosma
What's next in gene therapy for Crigler-Najjar syndrome? Expert opinion on biological therapy (2022)
Helena Costa-Verdera, Fanny Collaud, Christopher R Riling, Pauline Sellier, Jayme M L Nordin, G Michael Preston, Umut Cagin, Julien Fabregue, Simon Barral, Maryse Moya-Nilges, Jacomina Krijnse-Locker, Laetitia van Wittenberghe, Natalie Daniele, Bernard Gjata, Jeremie Cosette, Catalina Abad, Marcelo Simon-Sola, Severine Charles, Mathew Li, Marco Crosariol, Tom Antrilli, William J Quinn, David A Gross, Olivier Boyer, Xavier M Anguela, Sean M Armour, Pasqualina Colella, Giuseppe Ronzitti, Federico Mingozzi
Hepatic expression of GAA results in enhanced enzyme bioavailability in mice and non-human primates. Nature communications 12 (1) (2021)
Volha V Zhukouskaya, Louisa Jauze, Séverine Charles, Christian Leborgne, Stéphane Hilliquin, Jérémy Sadoine, Lotfi Slimani, Brigitte Baroukh, Laetitia van Wittenberghe, Nathalie Daniele, Fabienne Rajas, Agnès Linglart, Federico Mingozzi, Catherine Chaussain, Claire Bardet, Giuseppe Ronzitti
A novel therapeutic strategy for skeletal disorders: Proof of concept of gene therapy for X-linked hypophosphatemia. Science advances 7 (44) (2021)
Christian Leborgne, Elena Barbon, Jeffrey M Alexander, Hayley Hanby, Sandrine Delignat, Daniel M Cohen, Fanny Collaud, Saghana Muraleetharan, Dan Lupo, Joseph Silverberg, Karen Huang, Laetitia van Wittengerghe, Béatrice Marolleau, Adeline Miranda, Anna Fabiano, Victoria Daventure, Heena Beck, Xavier M Anguela, Giuseppe Ronzitti, Sean M Armour, Sébastien Lacroix-Desmazes, Federico Mingozzi
IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. Nature medicine 26 (7) (2020)
Francesco Puzzo, Pasqualina Colella, Maria Grazia Biferi, Deeksha Bali, Nicole K Paulk, Patrice Vidal, Fanny Collaud, Marcelo Simon-Sola, Severine Charles, Romain Hardet, Christian Leborgne, Amine Meliani, Mathilde Cohen-Tannoudji, Stephanie Astord, Bernard Gjata, Pauline Sellier, Laetitia van Wittenberghe, Alban Vignaud, Florence Boisgerault, Martine Barkats, Pascal Laforêt, Mark A Kay, Dwight D Koeberl, Giuseppe Ronzitti, Federico Mingozzi
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase. Science translational medicine 9 (418) (2018)

Giuseppe Ronzitti.css-eqlu8i{font-size:small;padding-left:4px;} (G Ronzitti)

Publication Activity (10 Years)

Top Topics

Top Venues

Giuseppe Ronzitti (G Ronzitti)